You have 9 free searches left this month | for more free features.

City

Boston (2)

Atlanta (1)

Columbus (1)

Shreveport (1)

Condition

GVHD (1)

Graft Versus Host Disease (1)

Hemoglobinopathies (1)

Sickle Cell Disease (1)

Thalassemia (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Dana-Farber Cancer Institute (2)

Collaborator

Brigham and Women's Hospital (2)

Beth Israel Deaconess Medical Center (1)

Emory University (1)

Feist-Weiller Cancer Center at Louisiana State University Health Sciences (1)

Massachusetts General Hospital (1)

Ohio State University (1)

Intervention

busulfex (2)

fludarabine (2)

alemtuzumab (1)

sirolimus (1)

stem cell transfusion (1)

tacrolimus (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

busulfex

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

GVHD, GVHD Trial in Boston (tacrolimus, sirolimus, fludarabine)

Completed

Has Results

Graft Versus Host Disease
GVHD

tacrolimus
+3 more

Boston, Massachusetts

Dana-Farber Cancer Institute

Apr 29, 2014

Hemoglobinopathies, Sickle Cell Disease, Thalassemia Trial in United States (Busulfex, Fludarabine, Alemtuzumab)

Completed

Has Results

Hemoglobinopathies
+2 more

Busulfex
+3 more

Atlanta, Georgia
+5 more

Jul 24, 2013